Skip to main content
Log in

Letter: are there incidences of clinically relevant psychiatric symptoms during glioblastoma treatment?

  • Correspondence
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Regli LKP, Huijs SMH, Pasmans RCOS et al (2023) Incidence of clinically relevant psychiatric symptoms during glioblastoma treatment: an exploratory study. J Neurooncol 163:185–194. https://doi.org/10.1007/s11060-023-04326-2

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Mistry AM, Jonathan SV, Monsour MA et al (2021) Impact of postoperative dexamethasone on survival, steroid dependency, and infections in newly diagnosed glioblastoma patients. Neurooncol Pract 8:589–600. https://doi.org/10.1093/nop/npab039

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Contributions

All authors contributed to the manuscript writing and review.

Corresponding author

Correspondence to Matthew J. Shepard.

Ethics declarations

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Onyiah, C., Shepard, M. Letter: are there incidences of clinically relevant psychiatric symptoms during glioblastoma treatment?. J Neurooncol 163, 729–730 (2023). https://doi.org/10.1007/s11060-023-04376-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-023-04376-6

Navigation